GlassScriptPhysician profile
Hakan S Charles Harris
NPI 1922086875
$3,094.67
in general payments reported to CMS, 2019-2025
27 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $565 · 2021: $754 · 2022: $1,120 · 2023: $111 · 2024: $47.04 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $497.07 | 2020-2022 | |
| Tela Bio, INC. | $463.54 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Silk Road Medical, INC. | $389.57 | 2022 | |
| Medtronic, INC. | $260.86 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Intuitive Surgical, INC. | $243.66 | 2019-2022 | |
| Smith+Nephew, INC. | $178.82 | 2019-2025 | Collagenase Santyl, Oasis, Grafix Pl |
| Davol INC. | $158.53 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $106.24 | 2019-2025 | Covera |
| Paratek Pharmaceuticals, INC. | $96.37 | 2020-2021 | |
| Kci USA, INC. | $82.35 | 2020-2023 | Prevena, V.A.C. Veraflo, Abthera |
| Sanara Medtech INC. | $61.33 | 2022-2023 | Celleraterx |
| Cumberland Pharmaceuticals, INC. | $59.35 | 2019 | |
| Acell, INC. | $52.88 | 2019-2020 | |
| Getinge USA Sales, LLC | $51.13 | 2022 | |
| Molnlycke Health Care US, LLC | $48.70 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $45.27 | 2019-2020 | |
| Organogenesis INC. | $42.41 | 2023-2024 | Puraply |
| Angiodynamics, INC. | $38.65 | 2020-2022 | |
| Stryker Corporation | $34.95 | 2025 | Spy-Phi System, 1788 |
| Pacira Pharmaceuticals Incorporated | $33.23 | 2025 | Exparel |
| Philips North America LLC | $28.28 | 2022 | |
| Solventum Corporation | $24.60 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Ethicon US, LLC | $24.43 | 2020 | |
| Amniox Medical, INC. | $20.57 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $19.53 | 2022 | |
| Neuros Medical, INC. | $18.22 | 2025 | Altius |
| Bioventus LLC | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hakan Charles Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.